|
MADRE (Mammograms Available Due to Research and Education)
RECRUITINGN/ASponsored by University of Illinois at Chicago
Actively Recruiting
PhaseN/A
SponsorUniversity of Illinois at Chicago
Started2023-03-14
Est. completion2027-08-31
Eligibility
Age40 Years – 74 Years
SexFEMALE
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →
NCT05841355
Summary
The design builds on past studies by integrating social network analysis (SNA) and implementation science (IS) into a longitudinal randomized clinical trial (RCT). The investigator will compare the long-term effects of interventions by examining guideline-concordant initial and repeat Breast Cancer (BC) screening.
Eligibility
Age: 40 Years – 74 YearsSex: FEMALEHealthy volunteers accepted
Aim 1 Inclusion Criteria: * female biological sex * identification as Latinas * non-adherence to USPSTF guidelines (42-74 years old, no mammogram in past 2 years, no previous BC diagnosis) * no previous history of health volunteerism * not a network member enrolled in Aim 2. Exclusion Criteria \* Not meeting at least one of the aforementioned Aim 1 inclusion criteria. Aim 2. Inclusion Criteria: * female biological sex * eligibility to obtain BC screenings by USPSTF guidelines (i.e., 40-74 years old, no personal BC history) * referral from Aim 1 participants * no previous history of health volunteerism * no participation in the RCT (not an Aim 1 participant, no Session #3 attendance). Exclusion Criteria: * Not meeting at least one of the aforementioned Aim 1 inclusion criteria.
Conditions3
Breast CancerBreast Cancer ScreeningCancer
Locations2 sites
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity of Illinois at Chicago
Started2023-03-14
Est. completion2027-08-31
Eligibility
Age40 Years – 74 Years
SexFEMALE
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →
NCT05841355